Ngày 11/8, Cơ quan Quản lý dược phẩm châu Âu (EMA) thông báo đã bắt đầu nghiên cứu 3 điều kiện mới để đánh giá liệu có thể có các tác dụng phụ liên quan đến vaccine ngừa COVID-19 theo công nghệ mRNA của hai hãng dược phẩm Mỹ là Pfizer và Moderna hay không.
Tin liên quan
-
{catetitle} - {publish}
{title}
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
(TTXVN/Vietnam+)
{name} - {time}
{body}
{name} - {time}
{body}
Ý kiến của bạn sẽ được biên tập trước khi đăng. Vui lòng gõ tiếng Việt có dấu
-
2025-01-13 14:21:00Kế hoạch Greenland của Trump “không phải là một ý tưởng điên rồ”
-
2025-01-13 14:01:00Chi tiêu quốc phòng toàn cầu tăng lên mức kỷ lục mới
-
2021-08-12 09:22:00Pháp áp dụng biện pháp cứng rắn, Bỉ bắt đầu dùng hộ chiếu vaccine
Nhật Bản: Hệ thống y tế tại thủ đô Tokyo đối diện nguy cơ quá tải
PAHO: Chưa tới 20% dân số Mỹ Latinh được tiêm đầy đủ vaccine
Mỹ hối thúc OPEC+ tăng sản lượng dầu để hỗ trợ đà phục hồi kinh tế
Dịch COVID-19: Châu Á là điểm nóng, châu Âu diễn biến phức tạp
Nga, Nhật Bản xem xét hoạt động kinh tế chung tại Nam Kuril
Tổng thống Iran lựa chọn nhân sự quan trọng trong nội các mới
Giới chuyên gia kêu gọi Mỹ mở kho dự trữ vaccine cho thế giới
Mỹ cáo buộc Taliban vi phạm thỏa thuận năm 2020 tại Afghanistan
Bộ trưởng Quốc phòng Nga, Mỹ điện đàm về chiến lược hạt nhân
Địa phương
Thời tiết
Bình luận
